Company intelligence / Profile preview

RxPharma

Watford, Hertfordshire, United Kingdom

Ownership: Private
Development stage: Other

Overview

RxPharma (also known as Rx Farma) is a UK-based specialty pharmaceutical company and a subsidiary of the Sigma Group. Established in 2000, the company focuses on the development, manufacturing, and distribution of high-quality, affordable generic medicines. Its portfolio includes a wide range of MHRA-approved products across therapeutic areas such as analgesics, anti-infectives, anti-diabetics, and gastroenterology. RxPharma serves both primary and secondary care sectors in the UK and is expanding its international presence through initiatives like Rx Malta.

Therapeutic areas: GastroenterologyEndocrinologyNeurologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Partnerships

Sigma Pharmaceuticals plc

Beyond the preview

Go deeper on RxPharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RxPharma.

Explore the full profile